In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance

In vitro activity of sulbactam-durlobactam against carbapenem-resistant Acinetobacter baumannii and mechanisms of resistance

ABSTRACT: Objectives: Multidrug-resistant Acinetobacter baumannii (MDR-Ab), particularly strains producing oxacillinase (OXA)-type carbapenemases, have rapidly emerged in health care settings as a frequent cause of serious infections with limited treatment options. This study evaluated the in vitro...

Full description

Bibliographic Details
Main Authors: Jacqueline Findlay, Laurent Poirel, Maxime Bouvier, Patrice Nordmann
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Journal of Global Antimicrobial Resistance
Subjects:
Carbapenemase
Acinetobacter baumannii
Aerobes
Sulbactam-durlobactam
Beta-lactamase inhibitor
Online Access:http://www.sciencedirect.com/science/article/pii/S2213716522001151

Internet

http://www.sciencedirect.com/science/article/pii/S2213716522001151

Similar Items